Über uns
Über uns
Führungsteam
Unsere Verantwortung
Kollaborationen
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Analysten-Coverage
Hauptversammlung
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Mechanism of Action
mRNA-Based Vaccines and Mode of Action
by Bettina Joedicke-Braas
Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction
by Sovereign
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
by Sovereign
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
by Sovereign
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
by Sovereign
Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
by Sovereign
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
by Sovereign
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
by Sovereign
Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals
by Sovereign
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
by Sovereign
1
2
3